2Crino L, Scagliotti G, Marangolo M, et al. Cisplatin-gemcitabine combination in advanced non small-celll lung cancer: A phase II study[J]. J Clin Oncol, 1997, 15(1): 297-303.
3Rosell R, Tonuto M. Sandler A. et al. The activity of gemcitabine plus cisplatin in randomized trials in untreated patients with advanced non-small-cell lung cancer[J]. J Semin Oncol, 1998. 25(4) : 27 - 34.
4Paul A, Bunn J. Triplet chemotherapy with gemcitabine, a platinum and third agent in the treatment of advanced non-small-cell lung cancer[J]. J Semin Oncol, 1999, 26(1) : 25-30.
二级参考文献8
1[1]Gatzemeier U, Shepherd FA, Le Chevalier T. Activity of gemcitabine in patients with non-small-cell lung cancer: A multicenter expanded phase Ⅱ study [J]. Eru J Cancer, 1996,32A: 243-248.
2[2]Hansen HH. Is there a role for chemotherapy of non-small-cell lung cancer [J]? Ann Oncol, 1995,6(Suppl 1):79-82.
3[3]Grilli R, Oxman AD, Jullian JA. Chemotherapy for advanced nonsmall-cell lung cancer: How much benefit is enough [J]? J Clin Oncol, 1993,11(10): 1866-1872.
4[4]Souquet PS. Chauvin F, Boisse JP, et al. Polychemotheray in advanced non-small-cell lung cancer: A meta-analysis [J]. Lancet,1993,342( 1 ): 19-21.
5[5]Marino P, Pampallona S, Preatoni A, et al. Chemotherapy cs.supportive care in advanced non-small-cell lung cancer: Results of a meta-analysis of the literature [J]. Chest, 1994,106(3) :861-865.
6[6]Non-small-Cell lung Cancer Collaborative Group: Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual partients from 52 randomized clinical trials [J]. BMJ,1995,311(10) :899-909.
7[7]American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer [J]. J Clin Oncol , 1997,15(8): 2996-3018.
8[8]CrinO L, Scagliotti G, Marangolo M, et al. Cisplatin-gemcitabine combination in advanced non-samll-cell lung cancer: A phase Ⅱstudy [J]. J Clin Oncol, 1997,15(1): 297-303.
7Huang X,Wong MK,Zhao Q,et al.Soluble recombinant endostatin purified from Escherichia coli:Antlangiogenic activity and antitumor effect[J].Cancer Res,2001,61(2):478-481.
8Eder JP,Supko JG,Clark JW,et al.Phase cllnicaltrial of ecombinant human endostratln administered as a short ntravenousinfuslon repeated daily[J].J Clin Oncol,2003,20(18):3772-3784.
9Shichiri M,Hirata Y.Antiangigenesis signals by endostatin[J].FASEB J,2001,15(6):1044-1053.
10Folkman J.Role of angiogenesis in tumor growth and metastasis[J].Semin Oncol,2002,29(Suppl):15-18.
